The Latest Morningside Graduate School of Biomedical Sciences News
Getting Results…
UMass Chan licenses RNA-based treatment for fragile X syndrome to QurAlis Corporation
UMass Chan licenses potential RNA-based treatment for fragile X syndrome to QurAlis Corporation.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, Neuroscience, Jonathan K. Watts, RNA Therapeutics Institute, Program in Molecular Medicine, Latest News, Clinical Trials, Top Stories,
Clinical trial participant receives first dose of UMass Chan-developed treatment for alopecia areata by Alys Pharmaceuticals
A siRNA therapeutic for dermatological diseases developed at UMass Chan Medical School has entered the clinical trial phase.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Dermatology, Faculty, Research, Anastasia Khvorova, SiRNA, John Harris, RNA Therapeutics Institute, Genetics, Latest News, Khvorova Lab, BRIDGE, Top Stories, Julia Alterman,
Educational Recognition Awards, Last Lecture celebrate UMass Chan’s collaborative environment
Mary Munson, PhD, receivedthe 2025 Chancellor’s Award for Excellence in Mentoring.
Read more
, Graduate School of Biomedical Sciences, Graduate School of Nursing, School of Medicine, Medicine, Clinician, Employee, Faculty, Student, Michael F. Collins, Education, Terence Flotte, Community, Biochemistry and Molecular Biotechnology, Pediatrics, Radiology, Surgery, Latest News, David Grunwald, Mary Munson, Top Stories, Chancellor,
